Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 24.18% is 33% below its 5-year average of 35.97%, near the low end of its 5-year range (24.18%–50.30%).
As of the fiscal period ended Tuesday, June 30, 2026. 36.93% below its 12-month average of 38.33%.
Reported quarterly debt to assets ratio; no daily interpolation. Q1 FY2027 (2026-06-30): 24.18%.
DEBT TO ASSETS RATIO
24.18%
DEBT TO ASSETS RATIO AVG TTM
38.33%
DEBT TO ASSETS RATIO AVG 3Y
39.88%
DEBT TO ASSETS RATIO AVG 5Y
35.97%
DEBT TO ASSETS RATIO AVG 10Y
29.53%
DEBT TO ASSETS RATIO AVG 15Y
26.70%
DEBT TO ASSETS RATIO AVG 20Y
20.30%
CURRENT VS TTM AVG
-36.93%
CURRENT VS 3Y AVG
-39.37%
CURRENT VS 5Y AVG
-32.78%
CURRENT VS 10Y AVG
-18.11%
CURRENT VS 15Y AVG
-9.44%
CURRENT VS 20Y AVG
+19.11%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+26763.65%
vs the sector median at left
Mesa Laboratories, Inc.
Market Cap
$761.37M
Debt to Assets Ratio
24.18%
TTM Avg
38.33%
3Y Avg
39.88%
5Y Avg
35.97%
Market Cap
$765.30M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$753.02M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$747.61M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$777.34M
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$778.01M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mesa Laboratories, Inc. (MLAB) | $761.37M | 24.18% | 38.33% | 39.88% | 35.97% |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | 0.17% | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | 0.03% | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $747.61M | 0.01% | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $776.24M | 0.24% | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | 0.24% | N/A | N/A | N/A |
| Varex Imaging Corporation (VREX)vs › | $778.01M | 0.34% | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $742.70M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | 0.48% | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | 0.02% | N/A | N/A | N/A |
Debt/Assets
24.2%
Debt/Equity
0.54
Current Ratio
2.07
Interest Coverage
1.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 24.18% |
| 2026-03-31 | 36.28% |
| 2025-12-31 | 41.62% |
| 2025-09-30 | 44.25% |
| 2025-06-30 | 45.35% |
| 2025-03-31 | 41.88% |
| 2024-12-31 | 48.41% |
| 2024-09-30 | 49.08% |
| 2024-06-30 | 50.30% |
| 2024-03-31 | 50.29% |
| 2023-12-31 | 31.83% |
| 2023-09-30 | 27.23% |
| 2023-06-30 | 27.75% |
| 2023-03-31 | 28.12% |
| 2022-12-31 | 28.51% |
| 2022-09-30 | 29.99% |
| 2022-06-30 | 31.58% |
| 2022-03-31 | 31.26% |
| 2021-12-31 | 32.13% |
| 2021-09-30 | 27.73% |
| 2021-06-30 | 27.54% |
| 2021-03-31 | 24.39% |
| 2020-12-31 | 23.38% |
| 2020-09-30 | 24.43% |
| 2020-06-30 | 24.73% |
| 2020-03-31 | 33.64% |
| 2019-12-31 | 33.09% |
| 2019-09-30 | 35.08% |
| 2019-06-30 | 13.19% |
| 2019-03-31 | 14.50% |
| 2018-12-31 | 18.47% |
| 2018-09-30 | 20.63% |
| 2018-06-30 | 24.41% |
| 2018-03-31 | 28.19% |
| 2017-12-31 | 33.44% |
| 2017-09-30 | 29.80% |
| 2017-06-30 | 29.92% |
| 2017-03-31 | 31.91% |
| 2016-12-31 | 31.09% |
| 2016-09-30 | 31.73% |
| 2016-06-30 | 28.38% |
| 2016-03-31 | 28.15% |
| 2015-12-31 | 30.30% |
| 2015-09-30 | 29.99% |
| 2015-06-30 | 21.33% |
| 2015-03-31 | 22.37% |
| 2014-12-31 | 24.10% |
| 2014-09-30 | 22.97% |
| 2014-06-30 | 25.39% |
| 2014-03-31 | 16.92% |
| 2013-12-31 | 17.29% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 2.35% |
| 2013-03-31 | 6.07% |
| 2012-12-31 | 7.86% |
| 2012-09-30 | 12.41% |
| 2012-06-30 | 16.49% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 3.48% |
| 2011-09-30 | 7.92% |
| 2011-06-30 | 11.97% |
| 2011-03-31 | 12.75% |
| 2010-12-31 | 13.65% |
| 2010-09-30 | 9.90% |
| 2010-06-30 | 10.72% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
